Inflow stenosis in arteriovenous fistulas and grafts: A multicenter, prospective study

Similar documents
The Art of Angioplasty

Interventional Treatment for Complete Occlusion of Arteriovenous Shunt: Our Experience in 39 cases

Case Endovascular management of non maturing dyalisis vascular access

CATHETER REDUCTION. Angelo N. Makris, M.D. Medical Director Chicago Access Care

Coding of Procedures in Interventional Nephrology Produced in collaboration with:

Angioplasty remains the most common method

Bare Metal Stents vs Stent Grafts

Supera for the Juxta-anastomotic AVF Stenosis

Introduction to the Native Arteriovenous Fistula: A primer for medical students and radiology residents

Endovascular Techniques for Dialysis Vascular Access

HD Scanning: Velocities and Volume Flow

TheSensitivityandSpecificityofClinicalExaminationoftheHemodialysisArterialVenousFistulaAVFasComparedtoAngiography

ASDIN 7th Annual Scientific Meeting DISCLOSURES TECHNICAL CONSIDERATIONS TECHNICAL CONSIDERATIONS UTILITY OF ULTRASOUND IN EVALUATING ACCESS

Why Can't I Cannulate This Fistula? Fistula Immaturity: The Simple But Critical Steps for a Functioning (Mature) AVF

Salvaging prosthetic dialysis fistulas with stents: Forearm versus upper arm grafts

Prospective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access

NON-MATURED ARTERIOVENOUS FISTULAE FOR HAEMODIALYSIS: DIAGNOSIS, ENDOVASCULAR AND SURGICAL TREATMENT

Decreased Incidence of Clotted AV Access in Hemodialysis Patients after the Implementation of Follow up Program

Case #1. Case #1- Possible codes. Unraveling the -59 modifier. Principles of Interventional. CASE 1: Simple angioplasty

Jimmy Wei Hwa Tan, Surg, MD

Ultrasound as a Tool for Preoperative Planning, Monitoring, and Interventions in Dialysis Arteriovenous Access

COVERA Vascular Covered Stents in the Management of Dysfunctional AV Access

Conversion of tunneled hemodialysis catheter consigned patients to arteriovenous fistula

IN.PACT AV Access IDE Study Full Baseline Data. Robert Lookstein, MD MHCDL New York, NY On Behalf of the IN.PACT AV ACCESS Investigators

During the 1980s and early 1990s, the arteriovenous

Lutonix in AV fistula and Early look AV IDE trial data

Fistula Maturation Failure. Successful AVF. ASDIN 2014 Scientific Meeting

4/29/2012. Management of Central Vein Stenoses. Central Venous Stenoses and Occlusions

Angiographic Changes following the Use of a Purse-String Suture Hemostasis Device in Hemodialysis Access Interventions

Coding of Procedures in Interventional Nephrology 2009

What s on the Horizon in Dialysis Access? Libby Watch, MD, FACS Miami Cardiac & Vascular Institute

Regardless of whether you are a vascular surgeon,

A P ilots tudy inevaluationof DysfunctionalHem odialysisvascular A ccessu sings yngoiflow

Postoperative AV Fistula Evaluation. Postoperative examination protocol. Postoperative AVF Protocol. Hemodialysis Access Surveillance

Distal Hypoperfusion Ischemic Syndrome (DHIS)

2006 NKF-DOQI Guidelines Preferred Vascular Access Order 1. Radiocephalic (wrist) fistula 2. Brachiocephalic (elbow) fistula 3. Basilic vein transposi

Thrombectomy, open, arteriovenous fistula without revision, autogenous or nonautogenous dialysis graft (separate procedure)

Department of Vascular Surgery, Maastricht University, Maastricht - The Netherlands 2

Lutonix AV Clinical Trial

Outcomes Of Combined Rheolytic And Rotational Mechanical Thrombectomy For Total Access Circuit Thrombosis In Hemodialysis Patients

Few occlusive problems in arteriovenous access

Coding of Procedures in Interventional Nephrology 2009

Percutaneous transluminal angioplasty in the treatment of stenosis of hemodialysis arteriovenous fistulae: our experience

Technical Aspects for Treating AV Dialysis Fistulae with the IN.PACT DCB. Andrew Holden Auckland Hospital Auckland, New Zealand

Lutonix AV Clinical Trial

The Role of LUTONIX 035 DCB in AV Fistula Dysfunction Management in our Practice

Since the initiation of hemodialysis, multiple inventions

Coding of Procedures in Interventional Nephrology 2012 (Revised March 26, 2012)

MIHÁLY TAPOLYAI, MD, FASN, FACP Associate Professor, Louisiana State University; Shreveport, Louisiana, USA Associate Professor; University of Hawai

Preoperative Venous Intimal Hyperplasia, Postoperative Arteriovenous Fistula Stenosis, and Clinical Fistula Outcomes

Interventions for AV-Shunt stenosis: What works best PTA, Stent or DCB?

Guidelines for Arteriovenous Access Intervention, Management and Abandonment, and for Removal of Pre- Study Dialysis Catheter

Hemodialysis arteriovenous access: Detection of stenosis and response to treatment by vascular access blood flow

All arteriovenous access circuits, whether native vein

Sid Bhende MD Sentara Vascular Specialists April 28 th Dialysis Access Review: Understanding the Access Options our Patients Face

The recent United States Renal Data System

Autogenous arteriovenous fistula for hemodialysis complicated with a giant venous aneurysm

Percutaneous thrombolysis of thrombosed haemodialysis access grafts: comparison of three mechanical devices

ASDIN 7th Annual Scientific Meeting

Balloon angioplasty for arteriovenous graft stenosis Anain P, Shenoy S, O'Brien M, Harris L M, Dryjski M

IGT versus AGT in AVG Salvage

Drug-eluting balloon for the treatment of failing hemodialytic arteriovenous fistulas

COVERA covered stent to treat stenosis in arteriovenous fistula: 6-month results from the prospective, multi-center, randomized AVeNEW study

PERCUTANEOUS TREATMENT OF THROMBOSED HEMODIALYSIS ARTERIOVENOUS FISTULAS: USE OF THROMBOASPIRATION AND BALLOON ANGIOPLASTY

Cephalic Arch Stenosis: A unique entity

LUTONIX AV Clinical Trial

Effectiveness and safety of dialysis vascular access procedures performed by interventional nephrologists

Surgical Options in Thrombectomy for Non-Surgeons

Selection of Permanent Hemodialysis Vascular Access

First experience with DCB for treatment of dialysis access stenosis The Greek experience

( GFR 30 ml/min/1.73m 2 ) [2] (Tunneled cuffed catheter) [1] [3]

Management of perianastomotic stenosis of direct wrist autogenous radial-cephalic arteriovenous accesses for dialysis

Preservation of Veins and Timing for Vascular Access

Outcome of a comprehensive follow-up program to enhance maturation of autogenous arteriovenous hemodialysis access

Evaluation of percutaneous transluminal angioplasty screening using color Doppler ultrasonography

Aggressive approach to salvage non-maturing arteriovenous fistulae: a retrospective study with follow-up

Vascular. Management Of The Immature Autogenous Arteriovenous Fistula. Theodore F. Saad DOI: /

Medical Director/Surgeon as Partners WebEx February 11, 2010

Thoughtful vs. Dogmatic

Mechanical thrombectomy in acute thrombosis of dialysis fistulas: a multi-center study

Ruolo della clinica e del laboratorio nella diagnosi di malfunzionamento di una FAV

Evaluation of Immature Hemodialysis Arteriovenous Fistulas Based on 3-French Retrograde Micropuncture of Brachial Artery

Safety of low-dose radiocontrast for interventional AV fistula salvage in stage 4 chronic kidney disease patients

Clinical Study Endovascular Stent Placement for Hemodialysis Arteriovenous Access Stenosis

DCB in the treatment of av-accessa single center prospective study

RadRx Your Prescription for Accurate Coding & Reimbursement Copyright All Rights Reserved.

AVF Prevalence. Local elastase to aid fistula maturation. I have nothing to disclose

Lutonix AV Clinical Trial

PERMANENT VASCULAR ACCESS consists

Outcomes of surgical revision of stenosed and thrombosed forearm arteriovenous fistulae for haemodialysis

Endovascular Declotting of Wall-Adherent Thrombi in Hemodialysis Vascular Access

Access Preservation: Recurrent Central Venous Stenosis, Pacemaker Wires and other Nightmares. Who am I? Disclosures

ENDOVASCULAR TREATMENT OF MALFUNCTIONING HAEMODIALYSIS GRAFTS/FISTULAS. Dr R Uberoi Interventional Radiologist John Radcliffe hospital Oxford.

Autogeneous Elbow Fistulas: the Effect of Diabetes mellitus on Maturation, Patency, and Complication Rates

*PTA Failure: Recoil >30% stenosis or more than 2 PTA s within 3 mo. Bart Dolmatch, MD

Measure #330: Adult Kidney Disease: Catheter Use for Greater Than or Equal to 90 Days National Quality Strategy Domain: Patient Safety

Role of Covered Stents and Drug Eluting Balloons In Dialysis Access

VASCULAR DISEASE MANAGEMENT 2013:10(1):E11-E15 Key words: subclavian artery, arteriovenous fistula, access site management

COVERA Vascular Covered Stents Innovation in AV Access

Transcription:

Kidney International, Vol. 67 (2005), pp. 1986 1992 Inflow stenosis in arteriovenous fistulas and grafts: A multicenter, prospective study ARIFASIF, FLORIN N. GADALEAN, DONNA MERRILL, GAUTAM CHERLA, CRISTIAN D. CIPLEU, DAVID L. EPSTEIN, and DAVID ROTH Department of Medicine Division of Nephrology, Section of Interventional Nephrology, University of Miami Miller School of Medicine, Miami, Florida; and Section of Interventional Nephrology, Kidney Specialists, San Antonio, Texas Inflow stenosis in arteriovenous fistulas and grafts: A multicenter, prospective study. Background. Traditionally, arteriovenous hemodialysis access inflow stenosis has been reported to occur infrequently (0% to 4%). In contrast, recent reports have suggested a significantly higher incidence (14% to 42%). Interpretation of these studies has been complicated by the presence of one or more confounding factors such as retrospective study design, small sample size, arteriovenous fistulas grouped with grafts to determine the incidence of inflow stenosis, inclusion of fistulas that had failed primarily, failure to provide adequate definition of inflow stenosis, and the technique of retrograde angiography. This is a report of a prospective, multicenter study to examine the incidence of inflow stenosis separately in arteriovenous fistulas and grafts. Methods. Patients were referred to interventional nephrology either for percutaneous balloon angioplasty or thrombectomy procedures. Angiography to evaluate access inflow (arterial anastomosis and adjacent vascular structures) was performed in all cases. This was accomplished by retrograde angiography using either manual occlusion of the venous side and/or advancing a diagnostic catheter across the arterial anastomosis. Multiple images using digital subtraction angiography were recorded in multiple planes. An inflow stenosis was defined as stenosis within the arterial system, artery-graft anastomosis (graft cases), artery-vein anastomosis (fistula cases) and juxtaanastomotic region (the first 2 cm downstream from the arterial anastomosis). Vascular stenosis was defined as 50% reduction in luminal diameter judged by comparison with either the adjacent vessel or graft. A standardized definition for anastomotic stenosis was applied. Results. Two hundred and twenty three consecutive procedures (grafts, 122; fistulas, 101) were performed in 158 patients. Inflow stenosis occurred in 36/122 (29%) in graft cases. All had a coexisting stenosis on the venous side. In fistula cases, 41/101 (40%) had inflow stenosis. Of these, 22 (54%) had a coexisting lesion on the venous side. Overall, inflow stenosis occurred in 77/223 procedures (35%). Keywords: inflow stenosis, arterial stenosis, hemodialysis access, interventional nephrology. Received for publication July 24, 2004 and in revised form September 29, 2004 Accepted for publication December 9, 2004 C 2005 by the International Society of Nephrology Conclusion. This prospective, multicenter study demonstrates that access inflow stenosis occurs in one third of the cases referred to interventional facilities with clinical evidence of venous stenosis or thrombosis. This is much higher than has been traditionally reported. The vascular access used for hemodialysis should be thought of as a complete circuit. This circuit begins with the heart, then the arterial system that leads to the arterial anastomosis, the fistula, or graft, and finally, the venous system that leads back to the heart. Access flow can be adversely affected by problems that occur anywhere within this complete circuit. Venous problems are the most common and have justifiably received a great deal of attention [1 4]. In contrast, stenosis on the arterial side has been reported to occur in only a minority (0% to 4%) of patients [3 7]. Recent data have suggested a significantly higher incidence of inflow stenosis (14% to 42%) in patients with arteriovenous access [8, 9]. However, the studies evaluating the incidence of inflow stenosis have been limited by the presence of one or more confounding factors such as retrospective study design [8], small sample size [8], lack of separation of arteriovenous fistulas from arteriovenouos grafts to determine the incidence of inflow stenosis [abstracts; Levine MI, JAm Soc Nephrol 10:209, 1999; Jahnke T, Cardiovasc Interven Radiol 24(Suppl 1):S184, 2001], inclusion of only those fistulas that had failed to develop adequately to support dialysis (primary failure) [9], and failure to provide an adequate definition of inflow stenosis. The purpose of this multicenter study was to prospectively examine the incidence of inflow stenosis separately in patients with arteriovenous grafts and arteriovenous fistulas undergoing either percutaneous balloon angioplasty (PTA) or thrombectomy procedures utilizing standardized definitions for stenosis. METHODS Study design The data for this prospective cohort study were derived from two interventional nephrology laboratories 1986

Asif et al: Inflow stenosis in vascular access 1987 (University of Miami Miller School of Medicine, Miami, Florida, and Kidney Specialists, San Antonio, Texas). Patients were referred for either PTA [access flow (Qa) less than 600 ml/min or Qa less than 1000 ml/min that has decreased by more than 25% over 4 months [1]] or treatment of thrombosed arteriovenous access (grafts or fistulas). PTA was performed utilizing a standard technique [10]. Both mechanical and pharmacomechanical techniques were used for thrombectomy procedures [2]. Two interventional nephrologists performed all of the procedures. The data were collected prospectively over a period of 1 year (June 2003 to June 2004). Definition of access inflow and degree of stenosis The inflow segment was defined as being comprised of that portion of the feeding artery adjacent to the anastomosis, the artery-graft anastomosis (for an arteriovenous graft), the artery-vein anastomosis (for an arteriovenous fistula) and the juxta-anastomotic access (2 cm downstream from the arterial anastomosis) [9]. Stenosis of either the juxta-anastomotic access or artery was defined as luminal narrowing equal to or exceeding 50% compared to the normal vascular segment located adjacent to the stenosis [1]. Based on a previous study addressing stenosis at the arterial anastomotic site [8], the same rule of 50% was applied to the arterial anastomosis where the comparison was made with the adjacent normal artery. The degree of stenosis was measured using calibrated computer software within the digital imaging system (C-Arm 9800 Vascular Package) (General Electric, Milwaukee, WI, USA). Description of the retrograde angiography To evaluate stenosis within the inflow segment, we performed retrograde angiography in all of the cases. In cases that were not thrombosed, retrograde angiography was performed by manually occluding the venous limb of the graft (in cases with arteriovenous grafts) or outflow tract (in cases with arteriovenous fistulas) to visualize the juxta-anastomotic access, arterial anastomosis, and adjacent portion of the feeding artery. In patients with a thrombosed access, a diagnostic catheter was advanced into the feeding artery to perform a retrograde examination. This was done in order to prevent flushing residual thrombus into the feeding arterial system in these cases. Images were recorded using digital subtraction angiography in multiple planes. Assessing the quality of access inflow The quality of the access inflow was evaluated using two different maneuvers assessing blood flow rate under fluoroscopy and by evaluating pulse augmentation. Blood flow rate was subjectively evaluated by injecting a small bolus of radiocontrast and watching the rate at which it traversed the access under fluoroscopy. Pulse augmentation, was performed by completely occluding the access several centimeters beyond the arterial anastomosis and evaluating the strength of the pulse between the anastomosis and the point of occlusion. Although these maneuvers are subjective assessments, they were found to accurately reflect the status of the access inflow when anatomic problems were found to exist. By performing these evaluations before angiographic evaluation of the inflow, suspicion of an anatomic problem was established. If less than what was judged to be optimum results persisted following a successful treatment of an observed access inflow problem as defined above, further angiographic evaluation of the feeding artery was performed. This evaluation was accomplished by advancing a diagnostic catheter over a guidewire into the subclavian artery and performing complete arteriography to reveal stenoses upstream as previously described [8]. Parameters recorded The incidence of inflow stenosis (including the degree of stenosis) and the location of stenosis within the inflow segment (artery, artery-graft anastomosis, arteryvein anastomosis, and juxta-anastomosis) were recorded. In addition, inflow stenosis cases demonstrating a coexisting lesion on the venous side were also recorded to report on the incidence of mixed stenoses. The success of angioplasty was defined as per the Dialysis Outcomes Quality Initiative (K/DOQI) vascular access guidelines ( 30% residual stenosis) [1]. The pre- and postangioplasty access flow (measured by ultrasound dilution technique within 2 weeks after angioplasty) was recorded for cases with patent accesses that were referred for PTA in all instances in which these studies could be accomplished. Statistical analysis The summary statistics of the patient s age as well as all other continuous variables were reported as mean ± standard deviation (SD). Comparison of continuous variables between pre- and postmeasurements and the incidence of inflow stenosis between arteriovenous grafts and fistulas were performed using paired t test. The P value was considered significant if < 0.05. All statistical analyses were done using Microsoft Office 2000 Software. RESULTS A total of 223 consecutive procedures (122 arteriovenousgrafts and 101 arteriovenous fistulas) were performed in 158 patients (77 arteriovenous grafts and 81 arteriovenous fistulas). One hundred and thirty cases were contributed by one center and ninety-three by the other. The procedures performed included 190 PTA and

1988 Asif et al: Inflow stenosis in vascular access Table 1. Demographics of the patient population Number of patients 158 Age years 55.9 ± 12.9 Gender Males 40% Race/Ethnicity Hispanic 68 (43%) African American 52 (33%) Caucasian 25 (16%) Haitian 9 (6%) Asian 4 (2%) Type of access Arteriovenous fistulas 81 (51%) Forearm fistulas 36 Upper Arm fistulas 45 Arteriovenous grafts 77 (49%) Loop grafts 73 Straight grafts 4 Cause of end-stage renal disease Hypertension 79 (49%) Diabetic nephropathy 60 (38%) Glomerulonephritis 10 (6%) HIV-associated nephropathy 4 (3%) Polycystic kidney disease 2 (1%) Lupus nephritis 2 (1%) Obstructive uropathy 1 (1%) HIV is human immunodeficiency virus. Results are expressed as mean ± SD. Table 2. Inflow and coexisting inflow and venous stenosis in arteriovenous grafts and fistulas Total inflow stenosis cases N = 77 Arteriovenous grafts with inflow stenosis N = 36 Presence of coexisting venous stenosis N = 36 (100%) Arteriovenous fistulas with inflow stenosis N = 41 Presence of coexisting venous stenosis N = 25 (57%) 33 thrombectomy procedures. Demographic characteristics of the 158 patients are shown in Table 1. In procedures involving arteriovenous grafts (N = 122), inflow stenosis was identified in 36 (29%) cases (Table 2). These 36 cases involved 47 stenotic lesions. The distribution of these 47 lesions was eight arterial (6.6% of total cases), 29 artery-graft anastomosis (23.8% of total cases), and ten juxta-anastomotic (8.2% of total cases). More than one lesion within the inflow segment was observed in 11 cases. All 36 cases demonstrated a coexisting stenosis on the venous side (Table 2) (Fig. 1). The incidence of inflow stenosis in arteriovenous grafts did not change even after exclusion of the juxtaanastomotic lesions from the calculations. All ten (8.2%) juxta-anastomotic lesions occurred in conjunction with an anastomotic stenosis. The demographic characteristics of the arteriovenous graft cases with inflow stenosis are shown in Table 3. In cases with arteriovenous fistulas (N = 101), inflow stenosis occurred in 41 (40%) (Table 2). A total of 58 stenotic lesions were seen in 41 cases. The distribution of the lesions along the inflow segment was eight arterial (8% of total cases), 21 artery-vein anastomosis (21% of total cases), and 29 juxta-anastomotic (29% of total Table 3. Characteristics of arteriovenous graft cases with inflow stenosis Total number of graft cases with inflow stenosis N = 36 Age years 51.4 ± 12.1 Gender Male 40% Etiology of end-stage renal disease Hypertension 16 (44%) Diabetes 18 (50%) Glomerulonephritis 1 (3%) Human immunodeficiency virus 1 (3%) Type of arteriovenous graft Forearm loop 35 (97%) Thigh loop 1 (3%) Data are expressed mean ± SD. Table 4. Characteristics of arteriovenous fistulas cases with inflow stenosis Total number of fistula cases with inflow stenosis N = 41 Age years 54 ± 11.2 Gender Male 45% Etiology of end-stage renal disease Hypertension 19 (46%) Diabetes 17 (42%) Glomerulonephritis 2 (6%) Human immunodeficiency virus 1 (2%) Polycystic kidney disease 1 (2%) Systemic lupus erythematosus 1 (2%) Type of arteriovenous fistula Upper arm fistula 18 (48%) Forearm fistula 23 (52%) Data are expressed mean ± SD. cases) (Figs. 3 to 5). Multiple lesions were found in ten cases (10% of total). A coexisting stenosis on the venous side was seen in 22 cases (54%) (Table 2) (Fig. 2). Out of the 101 arteriovenous fistula cases there were 36 forearm (radiocephalic) and 65 upper arm fistulas (brachiocephalic or brachiobasilic). There was higher incidence of inflow stenosis for the forearm as compared to the upper arm fistulas. Sixteen of the 36 (44%) radiocephalic arteriovenous fistulas had inflow stenosis while 25 of the 65 (38%) upper arm fistulas had inflow stenosis. Characteristics of patients with arteriovenous fistulas revealing inflow stenosis are shown in Table 4. Analysis of the 16 arterial lesions revealed that 11 (69%) were located adjacent to the arterial anastomosis (six arteriovenous grafts and five arteriovenous fistulas) (Fig. 1). Five cases (two arteriovenous grafts and three arteriovenous fistulas) (31%) had stenotic lesions located upstream in either the brachial (N = 2) or radial artery (N = 3) (Fig. 3). Overall (grafts and fistulas combined), inflow stenosis was diagnosed in 77/223 cases (35%). There was a significantly higher incidence of inflow stenosis in arteriovenous fistula cases (40% arteriovenous fistulas versus 29% arteriovenous grafts) (P < 0.01) (Table 2). Even after exclusion of the repeat procedures in 158 patients (77 arteriovenous grafts and 81 arterivenous fistulas), the

Asif et al: Inflow stenosis in vascular access 1989 Fig. 2. Arrows demonstrating juxta-anastomotic lesion in a forearm arteriovenous fistula (A). Note the presence of coexisting lesions in the body (double arrow) and outflow tract of the fistula (arrowhead). Resolution of stenoses after angioplasty (B and C). Fig. 1. Inflow stenosis located in the brachial artery (arrow) (C) just above the anastomosis in a patient with brachiocephalic arteriovenous graft. Notice a coexisting venous lesion in the same case (arrow) (A). Improvement of stenoses postangioplasty (D and B). flow failed to increase by 20% postangioplasty. Three of the 15 accesses with Qa increasing <20% occurred in cases with inflow stenosis (two arteriovenous graft and one arteriovenous fistula). incidence of inflow stenosis did not change significantly in grafts 24/77 (31%) or fistulas 34/81 (42%). The degree of inflow stenosis was found to be 69.7 ± 9.4% before angioplasty. After angioplasty, a residual lesion of 11.1 ± 9.7% was recorded. Out of the total 77 cases of inflow stenosis only one (arteriovenous fistula) demonstrated vascular spasm after angioplasty of juxtaanastomotic lesion that resolved within a few minutes. Pre- and postangioplasty flow studies were available in 174/190 of the cases that were referred for PTA. For the total group, postangioplasty flow showed a mean of 1099 ± 358 ml/min compared to a pretreatment value of 579 ± 204 ml/min. In cases with arteriovenous grafts (N = 93) the pre- and postangioplasty access flows were 588 ± 192 ml/min and 1120 ± 427 ml/min, respectively. Similarly, in cases of arteriovenous fistula (N = 81) the pre- and postangioplasty access flows were 570 ± 203 and 1076 ± 359 ml/min, respectively. In 15/174 cases (9%) access DISCUSSION Stenotic lesions can occur anywhere within the access system; however, lesions located at the inflow have been reported to occur infrequently [1, 3, 4]. Contrary to the traditional 0% to 4% incidence of inflow stenosis [3 7], recent studies have reported inflow stenosis in the range of 14% to 42% [8, 9] [abstracts; Levine MI, JAm Soc Nephrol 10:209, 1999; Jahnke T, Cardiovasc Interven Radiol 24 (Supple 1):S184, 2001]. The reasons for this discrepancy are undoubtedly multiple. However, the absence of an accepted definition of stenosis of the access inflow has been a major problem. This is particularly true for the arterial anastomosis. The arterial anastomosis is an artificially created structure for which there is no standard for judging optimum size. Size comparisons with the normal adjacent vessel and pressure difference across a suspect site are the two approaches most commonly used to diagnose stenosis within vascular structures. However,

1990 Asif et al: Inflow stenosis in vascular access Fig. 3. Multiple lesions seen in radial artery shown by arrows in a patient with radiocephalic fistula (A). Successful resolution of stenotic lesions following angioplasty (B). either of these techniques could be misleading in evaluating the arterial anastomosis. It is artificially created; its size is based upon the surgeon s judgment and in general is always smaller than the adjacent vessel and there is always a major drop in pressure across this site. There is a great need for a standard definition for what should be considered optimum for the size of the arterial anastomosis. The approach used in this study was to define stenosis at this site as narrowing equal to or exceeding 50% as compared to the adjacent vessel. This was based upon the criteria used in a previous study [8]. This definition is also consistent with the definition used by Beathard et al [9] based upon the appearance of an inflated angioplasty balloon placed across the anastomosis. A 50% defect in the balloon was required to be classified as a stenotic anastomosis. The balloon size selected for use was based upon the size of the artery,a4mmballoon was used to evaluate radial artery anastomoses and a 6 mm balloon was used for brachial artery anastomoses (Figs. 4 and 5). In addition to the size of the anastomosis, there is a lack of a universally accepted definition of the inflow segment itself. The definition used for this segment [feeding artery, artery-vein anastomosis and first 2 cm of the vein (juxta-anastomosis) in case of fistulas] is based on a recently published study [9]. The juxta-anastomotic region ( swing point) is located proximal to the body and the outflow tract of the fistula [9, 11 14]. Since the body and the outflow tract are the usual sites for arterial and venous needle placement, the swing point logically acts as the inflow to the fistula. In contrast to arteriovenous fistulas, the description of inflow segment in an arteriovenous graft is difficult. We used the same definition as was used for fistulae to describe inflow segment in graft cases. However, unlike fistulas we realize that the intragraft portion immediately after the anastomosis may not be considered part of the access inflow. Consequently, we also calculated the incidence of inflow stenosis in arteriovenous grafts after the exclusion of stenotic lesions located at the juxta-anastomotic region of the arteriovenous graft and found no difference, as all juxta-anastomotic stenoses (8.2%) existed in conjunction with artery-graft anastomotic lesions. In the current study, using the definitions described, the overall incidence of inflow stenosis (grafts and fistulas combined) was found to be 35%. In procedures with arteriovenous grafts (N = 122) the incidence was 29%. This finding is consistent with the study of Khan and Vesely [8] who reported a 27% incidence of arterial inflow lesions in patients with arteriovenouso grafts. These investigators further classified the arterial inflow lesions into arterial anastomotic and true arterial lesions. Using a standardized definition of significant stenosis ( 50% narrowing), they reported that a majority of the lesions were located at the arterial anastomosis (N = 10) and only a minority were true arterial lesions (N = 3). This report also demonstrated that inflow lesions are not limited to the area adjacent to the arterial anastomosis but may also be found proximally in the feeding artery (23%). In our cohort of patients with arteriovenous grafts, 47 stenotic lesions were seen (36 cases). Of these, eight (17%) were located proximally in the artery. The slightly decreased incidence of arterial lesions (17%) compared with the 23% reported by Khan and Vesely may be due to the fact that we did not perform complete arteriography by advancing the imaging catheter into the subclavian artery in every patient.

Asif et al: Inflow stenosis in vascular access 1991 Fig. 4. Anastomotic stenosis in a patient with brachiocephalic arteriovenous fistula as shown by arrow (A) and angioplasty balloon (B). Successful resolution of the stenosis after angioplasty (C and D). Although for the purpose of this study a retrograde arteriogram was routinely performed, the performance of this study in conjunction with routine interventional procedures such as these requires a clear medical indication. The maneuvers described in this report to evaluate inflow provide such an indication. While an evaluation of blood flow determined by observing the movement of a small bolus of contrast is subjective, the interventionalist experienced in the management of hemodialysis vascular access dysfunction can use it to advantage. Assessing pulse augmentation is also somewhat subjective, but with experience it becomes an excellent indicator of problems. In this study a high degree of correlation was seen between these subjective evaluations and the anatomical abnormalities that were detected. In the absence of the availability of intraprocedure determination of access flow [15], these maneuvers should be routinely performed in cases of vascular access dysfunction to determine if angiographic evaluation of the access inflow is medically indicated. In contrast to arteriovenous grafts, the incidence of inflow stenosis in our cohort with arteriovenous fistulas was 40%. In a previous study in which the incidence of inflow stenosis was studied in a prospective fashion in 46 patients with dysfunctional arteriovenous access (both grafts and fistulas) referred for PTA [abstract; Levine MI et al, J Am Soc Nephrol 10:209, 1999]. An inflow stenosis incidence of 39% was reported. The authors did not report any cases with proximal arterial stenosis; however, the study did not specify whether a complete evaluation of the arterial tree using arteriography was performed. In a study of early fistula failure [9] a 42% incidence of inflow stenosis was reported. In this report the technique of angiography as well as a clear-cut definition of the access inflow was clearly specified. Retrograde angiography was performed by manually occluding the fistula downstream. Fistula inflow was classified into feeding artery, arterial anastomosis and juxta-anastomotic region downstream. In this analysis, 38% of the cases had stenosis at the anastomosis, all in association with a juxtaanastomotic lesion. In addition, four lesions were seen in the artery above the anastomosis. Even though our fistula cohort included only ten patients with fistulas that had failed to develop primarily, our overall incidence of fistulas inflow stenosis (40%) was consistent with this report. This current study reports a significantly higher incidence of inflow stenosis in fistula cases compared to arteriovenous grafts (40% fistulas versus 29% grafts) (P < 0.01). The etiology of the higher incidence of inflow stenosis in patients with arteriovenous fistulas as compared to arteriovenous grafts is unclear. The juxta-anastomotic region in arteriovenous fistulas may provide a clue. This is the segment of the vein that is often mobilized and manipulated during the surgical creation of arteriovenous fistulas. One possible explanation may be the skeletonization of the vein and injury to its own blood supply (vasa vasorum) during the surgical procedure [11]. The higher incidence of inflow stenosis for the forearm arteriovenous fistulas seen in the current study was consistent with the previous investigators [12 14]. Previous reports have indicated that approximately one third of patients fail to show an increase in blood flow after successful angioplasty [7, 16, 17]. Although a number of factors may be responsible [16 20], undiagnosed inflow lesions may be a contributory factor. In this study, only 9% (15/174 cases) failed to increase the access flow by more than 20% after angioplasty. Three of the 15 accesses with Qa increasing <20% occurred in cases with inflow stenosis (two grafts and one fistula). The explanation for this failure of blood flow increment after successful angioplasty (residual lesion of <30%) in these cases is not obvious. The absence of an increase in flow may represent the redevelopment of stenosis due to an elastic lesion [18].

1992 Asif et al: Inflow stenosis in vascular access Fig. 5. Inflow stenosis located at the arterygraft anastomosis arrow (a). Resolution of stenosis postangioplasty (B). Note the irregularity of the brachial artery, however, the stenosis did not measure 50% (A). The result of this study suggests that the incidence of inflow stenosis is substantially higher than traditionally reported. The application of a standardized definition for the diagnosis of stenosis should be adopted and access inflow problems should be routinely considered. In the absence of objective measurements to indicate the status of blood flow within a dysfunctional access after all venous stenotic lesions have been addressed, subjective maneuvers such as those described here should be applied. Angiographic evaluation of access inflow should be evaluated in all cases in which there is suspicion of less than optimum flow. ACKNOWLEDGMENT This study was not supported by any grants or funding agencies. Reprint requests to Arif Asif, M.D., Director, Interventional Nephrology, Associate Professor of Medicine, University of Miami Miller School of Medicine, 1600 NW 10th Ave (R 7168), Miami, FL 33136. E-mail: Aasif@med.miami.edu REFERENCES 1. NATIONAL KIDNEY FOUNDATION: K/DOQI Clinical Practice Guidelines for Vascular Access: Update 2000. Am J Kidney Dis 37(Suppl 1):S137 S181, 2001 2. BEATHARD GA, WELCH BR, MAIDMENT HJ: Mechanical thrombolysis for the treatment of the thrombosed hemodialysis grafts. Radiology 200:711 716, 1996 3. BEATHARD GA: Angioplasty for arteriovenous grafts and fistulae. Semin Nephrol 22:202 210, 2002 4. KANTERMAN RY, VESELY TM, PILGRAM TK, et al: Dialysis access grafts: Anatomic location of venous stenosis and results of angioplasty. Radiology 195:135 139, 1995 5. SCHWAB SJ, HARRINGTON JT, SINGH A, et al: Vascular access for hemodialysis. Kidney Int 55:2078 2090, 1999 6. LILLY RZ, CARLTON D, BARKER J, et al: Predictors of arteriovenous graft patency after radiologic intervention in hemodialysis patients. Am J Kidney Dis 37:945 953, 2001 7. SCHWAB SJ, OLIVER MJ,SUHOCKI P, MCCANN R: Hemodialysis arteriovenous access: Detection of stenosis and response to treatment by vascular access blood flow. Kidney Int 59:358 362, 2001 8. KHAN FA, VESELY TM: Arterial problems associated with dysfunctional hemodialysis grafts: Evaluation of patients at high risk for arterial disease. JVasc Interv Radiol 13:1109 1114, 2002 9. BEATHARD GA, ARNOLD P, JACKSON J, LITCHFIELD T: Aggressive treatment of early fistula failure. Physician Operators Forum of RMS Lifeline. Kidney Int 64:1487 1494, 2003 10. BEATHARD GA: Percutaneous transvenous angioplasty in the treatment of vascular access stenosis. Kidney Int 42:1390 1397, 1992 11. VASSALOTTI JA: Arteriovenous fistulae stenosis: New terminology. Semin Dial 17:243, 2004 12. FALK A, TEODORESCU V, LOU WY, et al: Treatment of swing point stenoses in hemodialysis arteriovenous fistulae. Clin Nephrol 60: 35 41, 2003 13. TORDOIR JH, ROOYENS P, DAMMERS R, et al: Prospective evaluation of failure modes in autogenous radiocephalic wrist access for haemodialysis. Nephrol Dial Transplant 18: 378 383, 2003 14. TURMEL-RODRIGUES L, PENGLOAN J, BAUDIN S, et al: Treatment of stenosis and thrombosis in haemodialysis fistulas and grafts by interventional radiology. Nephrol Dial Transplant 15: 2029 2036, 2000 15. VESELY TM, GHERARDINI D, GLEED RD, et al: Use of a catheterbased system to measure blood flow in hemodialysis grafts during angioplasty procedures. JVasc Interv Radiol 13:371 378, 2002 16. VAN DER LINDEN J, SMITS JH, ASSINK JH, et al: Short- and longterm functional effects of percutaneous transluminal angioplasty in hemodialysis vascular access. J Am Soc Nephrol 13:715 720, 2002 17. AHYA SN, WINDUS DW, VESELY TM: Flow in hemodialysis grafts after angioplasty: Do radiologic criteria predict success? Kidney Int 59:1974 1978,2001 18. VESELY TM: Endovascular intervention for the failing vascular access. Adv Ren Replace Ther 9:99 108, 2002 19. BESARAB A, LUBKOWSKI T, VU A, et al: Effects of systemic hemodynamics on flow within vascular accesses used for hemodialysis. ASAIO J 47:501 506, 2001 20. BESARAB A, LUBKOWSKI T, FRINAK S, et al: Detecting vascular access dysfunction. ASAIO J 43:M539 M543, 1997